WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 61'1101 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 42'7901 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 5'619  5'598  5'575  5'551  5'524  5'338  5'140  5'123 
Births 64  64  64  64  64  66  62  57 
Surviving infants 63  63  63  64  64  65  62  56 
Pop. less than 5 years 323  326  327  326  326  338  291  313 
Pop. less than 15 years 987  992  996  997  1'002  986  875  1'067 
Female 15-49 years 1'255  1'257  1'257  1'256  1'253  1'253  1'306  1'224 

Number of reported case

(Click for retrospective incidence data for Denmark)
Diphtheria
Japanese encephalitis
Measles 17  84  14  180  28'249 
Mumps 60  15  13  32  17  34 
Pertussis 484  980  71  77  83  164  569  4'970 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Denmark)
Vaccine year result method % card seen                                                
BCG         
DTP1          97  97  94  93  90  95  98  97 
DTP3          94  94  91  90  89  97  90  88 
HepB_BD         
HepB3         
Hib3          94  94  91  90  89  95 
JapEnc         
MCV          89  90  87  85  84  100  84 
MCV2          86  87  86  85  85 
PCV1          95  95  92  89  86 
PCV3          94  93  90  88  86 
Pol3          94  94  91  90  89  97  99  99 
Rota1         
Rota_last         
Rubella1          86  90  87  85  84 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Denmark)
BCG
DTP1 97  97  94  93  90  98  98  97 
DTP3 94  94  91  90  89  97  90  88 
HepB3
HepB_BD
Hib3 94  94  91  90  89  95 
MCV 89  90  87  85  84  99  84 
MCV2 86  87  86  85  85 
PCV3 90  93  90  88  86 
Pol3 94  94  91  90  89  97  99  99 
Rota_last

Number of districts in the country 11  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 91
From 80 to 89% 9
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibIPV 3, 5, 12 months; Yes
DTaPIPV 5 years; Yes
HepB birth; 1, 2, 12 months; Yes Neonates of HBsAG pos mothers
HPV 12 years; +2, +6 months; Yes Only for girls at the age 12-14 years and women in the birth cohorte 85- 92
MMR 15 months; 4 years; Yes
Pneumo_conj 3, 5, 12 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes    No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number             NA 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 11  11  11  11   
Nº districts with DTP3 coverage >=80% number 11  11  11  11 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100   
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100%      

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes    Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%             100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.